成都大学学报（自然科学版）2023，Vol.42Issue(4)：337-341,353,6.DOI:10.3969/j.issn.1004-5422.2023.04.001
我国类改良型中药新药再评价研究现状
Research Status of Class-Modified Traditional Chinese Medicine New Drugs and Their Revaluation in China
摘要
Abstract
At present,there are some problems in the listed class-modified traditional Chinese medicine new drugs,such as different preparation processes,different dosage forms,different quality standards,dif-ferent usage and dosage.Combined with the idea of Chinese patent medicine reevaluation research,the au-thor discusses the revaluation research of listed class-modified traditional Chinese medicine new drugs in China,in order to provide reference for the research of class-modified traditional Chinese medicine new drugs.关键词
类改良型中药新药/低水平重复/再评价研究/研究现状Key words
class-modified traditional Chinese medicine new drugs/low-level repetition/revaluation re-search/research status分类
医药卫生引用本文复制引用
钟林江,卢文婷,蒋庆佳,李思成,唐焓嫣,罗琴琴,邓昊旻,潘迎志..我国类改良型中药新药再评价研究现状[J].成都大学学报（自然科学版）,2023,42(4):337-341,353,6.基金项目
四川省2021-2023年高等教育人才培养质量和教学改革项目(JG2021-1106) （JG2021-1106）
四川省科技创新苗子工程项目(2021054) （2021054）
新药中试四川省重点实验室开放课题资助项目(XYZS2022-01) （XYZS2022-01）
2021年四川省大学生创业训练计划项目(S202111079128S) （S202111079128S）
成都大学2021-2023年研究生人才培养质量和教学改革立项项目(cdjgy2022004) （cdjgy2022004）
